Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Revenue 2020–2025
Cytek Biosciences, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cytek Biosciences, Inc. revenue for the quarter ending March 31, 2026 was 44.1 M, a 6.46% increase year-over-year.
- Cytek Biosciences, Inc. revenue for the twelve months ending March 31, 2026 was 183.5 M, a 3.92% decrease year-over-year.
- Cytek Biosciences, Inc. annual revenue for 2025 was 201.5 M, a 0.52% increase from 2024.
- Cytek Biosciences, Inc. annual revenue for 2024 was 200.5 M, a 3.85% increase from 2023.
- Cytek Biosciences, Inc. annual revenue for 2023 was 193.0 M, a 17.67% increase from 2022.
- Cytek Biosciences, Inc. annual revenue for 2022 was 164.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytek Biosciences, Inc. Revenue — FAQ
Cytek Biosciences, Inc. (CTKB) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytek Biosciences, Inc.'s revenue?
Cytek Biosciences, Inc. (CTKB) reported revenue of $201M for fiscal 2025.
Where can I see CTKB's revenue history?
The chart and table above show Cytek Biosciences, Inc.'s revenue by year and by quarter, including the growth rate.